MWG Management Ltd.
Follow13F filer, CIK 1845151, Washington, DC
MWG Management Ltd. reported $58,687,054 across 3 holdings for the quarter ended 2025-03-31, in a 13F-HR filed 2025-05-13.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000950123-25-004952
- Period
- 2025-03-31
- Reported value
- $58.7M
- Holdings
- 3
- Top 10 weight
- 100%
- New
- 0
- Sold out
- 0
Holdings, Q1 2025
Share positions as resolved from 13F-HR 0000950123-25-004952, largest first. % of portfolio is the value over $58,687,054, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| BEAMBEAM THERAPEUTICS INC | 2,266,934 | $44.3M | 75.44% | 0 | Timeline | ||
| LYELL IMMUNOPHARMA INCLYELL IMMUNOPHARMA INC | 20,162,332 | $10.8M | 18.48% | 0 | |||
| PRMEPRIME MEDICINE INC | 1,792,210 | $3.57M | 6.08% | 0 | Timeline |
How Q1 2025 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0000950123-25-004952 | base | 2025-05-13 | acceptance time not in the bulk data set |